Bob Hugin Wiki
Bob Hugin Bio
|Robert John Hugin was born on 23rd July 1954. He is an American businessman and politician. A former executive chair of Celgene, a biopharmaceutical company, he is the Republican nominee for the United States Senate in New Jersey in the 2018 election.|
|Bob Hugin Personal details|
|Bob Hugin Age||23 July 1954 (age 64 years), Jersey City, New Jersey, United States|
|Bob Hugin Political party||Republican|
|Bob Hugin Wife||Kathy Hugin|
|Bob Hugin Children||3 including a daughter Hilary Hugin|
|Bob Hugin Education||Princeton University (BA)
University of Virginia (MBA)
|Bob Hugin Military service|
|Service/branch||The United States Marine Corps|
|Years of service||1976–1983 (active duty)
1983–1990 (reserve duty)
Bob Hugin Education and military service
At Princeton, Bob Hugin was president of the male-only Tiger Inn, one of the most prominent private eating clubs on campus. While working as president, he opposed the membership of gay men in 1976, stating that a member discovered to be gay “wouldn’t last long.” Years later, as a member of the alumni board, he also led the club’s opposition to a 13-year legal campaign during the 1980s and 1990s to require the club to admit women, comparing the campaign to “fascism.” In 2018, he said that his views on these issues had since changed.
Bob Hugin Career
From 1985 to 1999, Hugin worked at J.P. Morgan & Co. Inc. and was a managing director.
He has been credited with saving the biotech corporation Celgene and turning it profitable. He joined the company in June 1999 as senior vice president and CFO. In December 2001, he was elected to Celgene’s board of directors. Hugin served as Celgene’s president and COO since May 2006 and became the CEO of Celgene in June 2010. He was elected chairman of the Celgene board of directors in June 2011. In his time at Celgene, the market capitalization of the company went from $100 million to $70 billion, and headcount grew to 6,000.
During Hugin’s tenure, Celgene was reprimanded multiple times by the U.S Food and Drug Administration, including a formal warning letter in 2000 for not sharing all the risks associated with their drugs, and for marketing their drug Thalomid and others to doctors for unapproved uses. In 2017, Celgene was forced to pay $280 million in response to a lawsuit regarding these practices. Hugin has been criticized for drastically raising the prices of several drugs while he was in charge of Celgene. For example, in 2006, the drug Revlimid was introduced to the market and cost about $6,000 for a one-month supply. Celgene was able to prevent generic versions of the drug from being sold actively, and by the year 2017, the price for the same amount of Revlimid had been raised by Celgene to over $16,000.
In 2013, Hugin was named the best CEO in biotech by TheStreet.com. He left his position at Celgene as chief executive and became an executive chairman in 2017.
Bob Hugin 2018 U.S. Senate election
On 13th February 2018, Hugin announced his candidacy for the U.S. Senate in New Jersey. In the first quarter of 2018, his campaign raised a little under $8 million, of which $7.5 million was a loan from Hugin himself. He defeated Brian Goldberg in the Republican primary that took place on 5th June 2018, by garnering 75% of the vote, to Goldberg’s 24%. He will face Senator Bob Menendez in the general election on 6th November 2018.
Bob Hugin Wife and Children
Bob Hugin is married to Kathy Hugin. They have three children. Hugin is a member of the United Methodist Church. He and his wife earned more than $34 million between 2015 and 2016.